Abstract:Inhibition of transient receptor potential vanilloid 1 (TRPV1) significantly reduced brain tissue damage and cerebral inflammation and limited neurodegeneration after ICH. Inhibition of TRPV1 attenuated hemin‐induced apoptosis and preserved mitochondrial integrity by reducing Ca2+ influx and CaMKII‐P38 and c‐Jun NH2‐terminal kinase mitogen‐activated protein kinase signaling in vitro. Inhibition of TRPV1 may protect against ICH‐induced brain injury by modulating mitochondria‐related neuronal apoptosis and inflammatory responses. Intracerebral hemorrhage (ICH) induces a complex sequence of apoptotic cascades and inflammatory responses, leading to neurological impairment. Transient receptor potential vanilloid 1 (TRPV1), a nonselective cation channel with high calcium permeability, has been implicated in neuronal apoptosis and inflammatory responses. This study used a mouse ICH model and neuronal cultures to examine whether TRPV1 activation exacerbates brain damage and neurological deficits by promoting neuronal apoptosis and neuroinflammation. ICH was induced by injecting collagenase in both wild‐type (WT) C57BL/6 mice and TRPV1−/− mice. Capsaicin (CAP; a TRPV1 agonist) or capsazepine (a TRPV1 antagonist) was administered by intracerebroventricular injection 30 min before ICH induction in WT mice. The effects of genetic deletion or pharmacological inhibition of TRPV1 using CAP or capsazepine on motor deficits, histological damage, apoptotic responses, blood–brain barrier (BBB) permeability, and neuroinflammatory reactions were explored. The antiapoptotic mechanisms and calcium influx induced by TRPV1 inactivation were investigated in cultured hemin‐stimulated neurons. TRPV1 expression was upregulated in the hemorrhagic brain, and TRPV1 was expressed in neurons, microglia, and astrocytes after ICH. Genetic deletion of TRPV1 significantly attenuated motor deficits and brain atrophy for up to 28 days. Deletion of TRPV1 also reduced brain damage, neurodegeneration, microglial activation, cytokine expression, and cell apoptosis at 1 day post‐ICH. Similarly, the administration of CAP ameliorated brain damage, neurodegeneration, brain edema, BBB permeability, and cytokine expression at 1 day post‐ICH. In primary neuronal cultures, pharmacological inactivation of TRPV1 by CAP attenuated neuronal vulnerability to hemin‐induced injury, suppressed apoptosis, and preserved mitochondrial integrity in vitro. Mechanistically, CAP reduced hemin‐stimulated calcium influx and prevented the phosphorylation of CaMKII in cultured neurons, which was associated with reduced activation of P38 and c‐Jun NH2‐terminal kinase mitogen‐activated protein kinase signaling. Our results suggest that TRPV1 inhibition may be a potential therapy for ICH by suppressing mitochondria‐related neuronal apoptosis.

Inhibition of Intracellular Proton-Sensitive Ca2+-permeable TRPV3 Channels Protects Against Ischemic Brain Injury.

Disruption Of Ip(3)R2-Mediated Ca2+ Signaling Pathway In Astrocytes Ameliorates Neuronal Death And Brain Damage While Reducing Behavioral Deficits After Focal Ischemic Stroke

Transient receptor potential vanilloid 1 inhibition reduces brain damage by suppressing neuronal apoptosis after intracerebral hemorrhage

Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats.

Dual Role of TRPV1 Channels in Cerebral Stroke: An Exploration from a Mechanistic and Therapeutic Perspective

TRPV4 Blockade Preserves the Blood–Brain Barrier by Inhibiting Stress Fiber Formation in a Rat Model of Intracerebral Hemorrhage

Inhibition of Transient Receptor Potential Vanilloid 1 Attenuates Blood-Brain Barrier Disruption after Traumatic Brain Injury in Mice

Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP.

TRPM2 in ischemic stroke: Structure, molecular mechanisms, and drug intervention

Blockage of Transient Receptor Potential Vanilloid 4 Alleviates Myocardial Ischemia/Reperfusion Injury in Mice

Targeting TRPM channels for cerebral ischemia-reperfusion injury

The Role of TRPC Channels in Ischemic Neuronal Cell Death

The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke

Abstract TP286: the Study of the Role and Mechanism of TRPM7 in Acute Cerebral Ischemia-Reperfusion Injury

The Role of Transient Receptor Potential Channels in Blood-Brain Barrier Dysfunction after Ischemic Stroke

TRPC6 Inhibited NMDA Receptor Activities and Protected Neurons from Ischemic Excitotoxicity

TRPM2 Channel Deficiency Prevents Delayed Cytosolic Zn 2+ Accumulation and CA1 Pyramidal Neuronal Death after Transient Global Ischemia

Ischemic Neuronal Cell Death Mediated By Trpc Channels

TRPC6 Attenuates Cortical Astrocytic Apoptosis and Inflammation in Cerebral Ischemic/Reperfusion Injury

Sexually Dimorphic Response of TRPM2 Inhibition Following Cardiac Arrest-Induced Global Cerebral Ischemia in Mice

Contribution of TRPC Channels in Neuronal Excitotoxicity Associated With Neurodegenerative Disease and Ischemic Stroke